Johnson & Johnson Raritan , NJ 08869
Posted 1 week ago
Janssen Research & Development, LLC is recruiting for a Senior Financial Analyst, Oncology TA. The ideal candidate will be located in Spring House, PA, Raritan, NJ, or Titusville, NJ.
At the Janssen Pharmaceutical Companies of Johnson & Johnson, we are working to create a world without disease. Transforming lives by finding new and better ways to prevent, intercept, treat and cure disease inspires us. We bring together the best minds and pursue the most promising science. We are Janssen. We collaborate with the world for the health of everyone in it. Learn more at www.janssen.com and follow us @JanssenGlobal. Janssen Research & Development is part of the Janssen Pharmaceutical Companies.
The Senior Financial Analyst will be responsible for providing financial leadership, support and analysis to several key early and late stage development compounds within the Oncology Therapeutic Area. The position is responsible for all financial aspects related to the projects and functional budgets for their assigned compounds.
Responsibilities:
Proactively partner with Compound Development Teams (CDT) and Project Management Teams (PMT) to align financial targets, analyze the value of project investments, and address business issues
Manage all aspects of financial updates including Business Plan and Long Range Financial Plan and ensure the accuracy and compliance of monthly forecasting and closing cycles
Pipeline valuation models for their compounds, which includes partnering with CDT/PMT, Commercial, Global Strategic Marketing, Operations and Tax
Support of Cross-Pharmaceutical Portfolio Reviews and ad-hoc valuation support to key stakeholders across the Pharmaceutical R&D, Operations and Strategic Marketing organization
Partner with Business Development in support of External Innovation and L&A/M&A projects
The ability to challenge business assumptions, develop alternative scenarios and educate business partners on financial issues and concepts will be required. The candidate must demonstrate strong financial leadership by providing recommendations for improving the value of the financial information supplied to upper management, providing guidance to business partners, and executing the process for all development forecast and worldwide valuation updates for his/her compounds.
Johnson & Johnson